Table 2. Patients' clinical characteristics.

Patient n°	Age	Sex	Histological type	Breslow score (mm)	Stade	Metastasis	Response	Survival (month)
1	85	Female	Desmoplastic	4	IIIC	Skin, lymph node	PR	18†
2	87	Female	Mucosal	N/A	II (*)		PD	6†
3	88	Female	Lentigo maligna	3,1	IV M1b	Lung, Lymph node	SD	21No treatment
4	77	Male	Lentigo maligna	11	IV M1b	Lung, skin	PD	13†
5	66	Female	N/A	2,6	IIIC	Skin, lymph node	PD	1Ipilimumab
6	95	Male	Superficial-spreading	3,5	IV M1b	Lung, skin, lymph node	PD	3†
7	62	Male	Superficial-spreading	1,1	IV M1c	Lung, lymph node, liver, bone, thyroide	PD	8†
8	69	Male	N/A	3,5	IV M1b	Lung	PD	12Ipilimumab
9	44	Female	Superficial-spreading	1,6	IV M1c	Lung, lymph node, liver, brain	PD	3†
10	74	Female	Acral-lentiginous	2,4	IIIC	Skin	SD	9No treatment
11	72	Female	Superficial-spreading	1,31	IV M1a	Skin, lymph node	PD	9†

PD: progressive disease.

PR: partial response.

SD: stable disease.

^†: dead.

(*): Patient n°2 was inoperable, due to initial extension of its nasal tumor.